Birchview Capital’s NxStage Medical Inc. NXTM Stock Holding History

Birchview Capital’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-34,200	Closed	-$857K	–	45
2017 Q2	$857K	Buy	34,200 +6,000	+21%	+$149K	0.45%	14
2017 Q1	$757K	Hold	28,200	–	–	0.42%	17
2016 Q4	$739K	Hold	28,200	–	–	0.45%	14
2016 Q3	$705K	Hold	28,200	–	–	0.41%	17
2016 Q2	$611K	Hold	28,200	–	–	0.44%	17
2016 Q1	$423K	Buy	28,200 +2,500	+10%	+$41.9K	0.3%	23
2015 Q4	$563K	Buy	25,700 +11,000	+75%	+$205K	0.32%	21
2015 Q3	$232K	Hold	14,700	–	–	0.15%	37
2015 Q2	$210K	Hold	14,700	–	–	0.11%	39
2015 Q1	$254K	Hold	14,700	–	–	0.13%	36
2014 Q4	$264K	Buy	+14,700	New	+$237K	0.15%	32

Other funds holding NXTM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Birchview Capital's NXTM Position: Q3 2017 in Review

Birchview Capital sold out of NxStage Medical Inc. (NXTM) in Q3 2017, closing a stake of 34,200 shares — an estimated $857K sold.

Birchview Capital first reported a position in NXTM in Q4 2014 and held it in 11 quarters. The position peaked at $857K in Q2 2017. 168 funds tracked by Wall St. Rank hold NXTM as of Q3 2017.

Birchview Capital reported no remaining NxStage Medical Inc. position as of Q3 2017 after selling out during the quarter.
Birchview Capital sold 34,200 NxStage Medical Inc. shares in Q3 2017, an estimated $857K.
Birchview Capital first reported a position in NxStage Medical Inc. in Q4 2014 and held it in 11 quarters.
Birchview Capital's NxStage Medical Inc. position peaked at $857K in Q2 2017.
168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2017.

Based on Birchview Capital's 13F filing for Q3 2017, filed 2 Nov 2017.